Hospital Costs

• 

  Subject Areas on Research

  • A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). 
  • A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. 
  • A novel approach to maintain planned dose chemotherapy on time: a decision-making tool to improve patient care. 
  • A study of 11,003 patients with hypertrophic pyloric stenosis and the association between surgeon and hospital volume and outcomes. 
  • Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry. 
  • Acute and long-term cost implications of coronary stenting. 
  • Addition of price transparency to an education and feedback intervention reduces utilization of inpatient echocardiography by resident physicians. 
  • Administration of Oral Acetaminophen to Reduce Costs for the Hysterectomy Patient at a Community Hospital. 
  • Advancing Value-Based Models for Heart Failure: A Call to Action From the Value in Healthcare Initiative's Value-Based Models Learning Collaborative. 
  • Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. 
  • All-Polyethylene Tibia: An Opportunity for Value-Based Care in Bundled Reimbursement Initiatives. 
  • Alvimopan Provides Additional Improvement in Outcomes and Cost Savings in Enhanced Recovery Colorectal Surgery. 
  • An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but nondiagnostic electrocardiograms: Results from a randomized trial. 
  • An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection. 
  • Analytic considerations in economic evaluations of multinational cardiovascular clinical trials. 
  • Assertive community treatment for people with severe mental illness: the effect on hospital use and costs. 
  • Assessing the clinical and economic burden of coronary artery disease: 1986-1998. 
  • Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. 
  • Associations between worsening renal function and 30-day outcomes among Medicare beneficiaries hospitalized with heart failure. 
  • Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry. 
  • Better health, lower spending. 
  • Case mix-adjusted cost of colectomy at low-, middle-, and high-volume academic centers. 
  • Center variation in hospital costs for patients undergoing congenital heart surgery. 
  • Characteristics of Acute Heart Failure Hospitalizations Based on Presenting Severity. 
  • Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis. 
  • Chest X-ray after tracheostomy is not necessary unless clinically indicated. 
  • Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. 
  • Comorbid illness affects hospital costs related to hip arthroplasty: quantification of health status and implications for fair reimbursement and surgeon comparisons. 
  • Comparative analysis of length of stay, hospitalization costs, opioid use, and discharge status among spine surgery patients with postoperative pain management including intravenous versus oral acetaminophen. 
  • Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience. 
  • Comparison of hospital costing methods in an economic evaluation of a multinational clinical trial. 
  • Complications and Resource Use Associated With Surgery for Chiari Malformation Type 1 in Adults: A Population Perspective. 
  • Complications, reoperation rates, and health-care cost following surgical treatment of lumbar spondylolisthesis. 
  • Comprehensive support of family caregivers: Are there health system cost offsets? 
  • Cost analysis of remifentanil and fentanyl for neurosurgical anesthesia. 
  • Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. 
  • Cost and health care utilization in ARDS--different from other critical illness? 
  • Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience. 
  • Cost effectiveness of abciximab during routine medical practice. 
  • Cost implications of selective preoperative risk screening in the care of candidates for peripheral vascular operations. 
  • Cost of achieving equivalent outcomes in sicker patients after liver transplant. 
  • Cost of invasive fungal infections in the era of new diagnostics and expanded treatment options. 
  • Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network. 
  • Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation. 
  • Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial. 
  • Cost-effectiveness of fetal lung maturity testing in preterm labor. 
  • Costs and Benefits Associated With Transradial Versus Transfemoral Percutaneous Coronary Intervention in China. 
  • Costs associated with health care-associated infections in cardiac surgery. 
  • Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004. 
  • Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. 
  • Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST). 
  • Demonstrating the relationships of length of stay, cost and clinical outcomes in a simulated NICU. 
  • Diabetes and early postoperative outcomes following lumbar fusion. 
  • Direct and indirect costs for hospitalized patients with dengue in Southern Sri Lanka. 
  • Disease Burden Following Non-Cardioembolic Minor Ischemic Stroke or High-Risk TIA: A GWTG-Stroke Study. 
  • Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled Trial. 
  • Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease. 
  • Economic Outcomes of Extracorporeal Membrane Oxygenation With and Without Ambulation as a Bridge to Lung Transplantation. 
  • Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms. 
  • Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction. 
  • Economic assessment of thrombocytopenia: CATCH Registry. 
  • Economic effects of beta-blocker therapy in patients with heart failure. 
  • Economic impact of drug-eluting stents on hospital systems: a disease-state model. 
  • Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump. 
  • Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Use of abciximab: comparative economic data. 
  • Economics of low-molecular weight heparins. 
  • Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial. 
  • Effect of a disposable automated suturing device on cost and operating room time in benign total laparoscopic hysterectomy procedures. 
  • Effect of facility on the operative costs of distal radius fractures. 
  • Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. 
  • Effect of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit on total hospital cost. 
  • Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. 
  • Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy. 
  • Effect of repair strategy on hospital cost for infants with tetralogy of Fallot. 
  • Effect of the Deyo score on outcomes and costs in shoulder arthroplasty patients. 
  • Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. 
  • Epidemiology of facial fracture injuries. 
  • Estimating the Annual Incremental Cost of Several Complications Following Pulmonary Lobectomy. 
  • Estimating the Cost of Neurosurgical Procedures in a Low-Income Setting: An Observational Economic Analysis. 
  • Evidence-based use of colony-stimulating factors in elderly cancer patients. 
  • Evolving Cost-Quality Relationship in Pediatric Heart Surgery. 
  • Excess costs associated with complications and prolonged length of stay after congenital heart surgery. 
  • Factors Associated With Head and Neck Cancer Hospitalization Cost and Length of Stay-A National Study. 
  • Factors Influencing Hospitalization Rates and Inpatient Cost of Patients with Tuberculosis in Jiangsu Province, China: An Uncontrolled before and after Study. 
  • Financial Effect of Unbundling Moderate Sedation from Procedural Codes in Radiology. 
  • Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. 
  • Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives. 
  • Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency. 
  • Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment. 
  • Geographic variation in lumbar fusion for degenerative disorders: 1990 to 2000. 
  • Geographic variation in resource use for coronary artery bypass surgery. IHD Port Investigators. 
  • Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. 
  • Hand Sanitizer as an Alternative to Ultrasound Transmission Gel. 
  • Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus infection. 
  • Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. 
  • Hospital costs, incidence, and inhospital mortality rates of traumatic subdural hematoma in the United States. 
  • Hospital ownership and cost and quality of care: is there a dime's worth of difference? 
  • Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry. 
  • Hospital-based emergency department visits in children with motor vehicle traffic accidents: estimates from the nationwide emergency department sample. 
  • Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. 
  • Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). 
  • Impact of advance care planning on the care of patients with heart failure: study protocol for a randomized controlled trial. 
  • Impact of alternative reimbursement strategies in the new cooperative medical scheme on caesarean delivery rates: a mixed-method study in rural China. 
  • Impact of complications on outcomes following aortic and mitral valve replacements in the United States. 
  • Impact of cost valuation on cost-effectiveness in adult spine deformity surgery. 
  • Impact of the COVID-19 pandemic on a tertiary care public hospital in Singapore: resources and economic costs. 
  • Improving the Efficiency of Care for Pediatric Patients Hospitalized With Asthma. 
  • In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin. 
  • In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial). 
  • Incidence and occurrence of total (first-ever and recurrent) stroke. 
  • Incremental cost-effectiveness of evidence-based non-surgical weight loss strategies. 
  • Index and follow-up costs of endovascular abdominal aortic aneurysm repair from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS). 
  • Infective endocarditis and solid organ transplantation: Only worse outcomes during initial transplantation hospitalization. 
  • Intraoperative echocardiography during congenital heart operations: experience from 1,000 cases. 
  • Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations. 
  • Investment in new technology research can save future health care dollars. 
  • Is Bigger Better?: The Effect of Hospital Consolidation on Index Hospitalization Costs and Outcomes Among Privately Insured Recipients of Immediate Breast Reconstruction. 
  • Ketorolac is underutilized after ureteral reimplantation despite reduced hospital cost and reduced length of stay. 
  • Laparoscopic vs open right hepatectomy: a value-based analysis. 
  • Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. 
  • Line authority for nurse staffing and costs for acute inpatient care. 
  • Long-Term Outcomes Among Elderly Survivors of Out-of-Hospital Cardiac Arrest. 
  • Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial. 
  • Long-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia*. 
  • Loop ileostomy closure at an ambulatory surgery facility: a safe and cost-effective alternative to routine hospitalization. 
  • Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group. 
  • Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. 
  • Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. 
  • Modeling the Potential Economic Impact of the Medicare Comprehensive Care for Joint Replacement Episode-Based Payment Model. 
  • Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. 
  • Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. 
  • Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. 
  • National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States. 
  • National trends and predictors of mastectomy with immediate breast reconstruction. 
  • National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. 
  • No Changes in Patient Selection and Value-Based Metrics for Total Hip Arthroplasty After Comprehensive Care for Joint Replacement Bundle Implementation at a Single Center. 
  • Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? 
  • Nurse staffing and patient care costs in acute inpatient nursing units. 
  • Occurrence and complications of tracheal reintubation in critically ill adults. 
  • Opioid abuse in children: an emerging public health crisis in the United States! 
  • Optimising outcomes: socioeconomic perspective. 
  • Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients. 
  • Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures. 
  • Patient Factors and Cost Associated with 90-Day Readmission Following Total Hip Arthroplasty. 
  • Patients' preferences explain a small but significant share of regional variation in medicare spending. 
  • Patterns of inpatient care for prostate cancer in men with spina bifida. 
  • Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). 
  • Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. 
  • Post-procedure heparin: boon or burden? 
  • Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial. 
  • Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. 
  • Pre- Versus Post-Procedure Health Care Resource Utilization in Patients Undergoing Commercial Transcatheter Mitral Valve Repair. 
  • Predictors of costs of caring for elderly patients discharged with heart failure. 
  • Predictors of operative time during radical retropubic prostatectomy and robot-assisted laparoscopic prostatectomy. 
  • Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. 
  • Quality and Cost of Care by Hospital Teaching Status: What Are the Differences? 
  • Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome. 
  • Quality of life after treatment for pancreatitis. 
  • Randomized Trial of Population-Based Clinical Decision Support to Facilitate Care Transitions. 
  • Randomized clinical trial of an emergency department observation syncope protocol versus routine inpatient admission. 
  • Randomized trial of a nurse-administered, telephone-based disease management program for patients with heart failure. 
  • Reaching the medicare allowable threshold in adult spinal deformity surgery: multicenter cost analysis comparing actual direct hospital costs versus what the government will pay. 
  • Readmission rates and long-term hospital costs among survivors of an in-hospital cardiac arrest. 
  • Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs. 
  • Relationship between occurrence of surgical complications and hospital finances. 
  • Removing a constraint on hospital utilization: a natural experiment in Maryland. 
  • Resource use in the last 6 months of life among patients with heart failure in Canada. 
  • Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). 
  • Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. 
  • Seizure Correlates with Prolonged Hospital Stay, Increased Costs, and Increased Mortality in Nontraumatic Subdural Hematoma. 
  • Seriously ill hospitalized adults: do we spend less on older patients? Support Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatments. 
  • Short-term costs associated with primary prophylactic G-CSF use during chemotherapy. 
  • Simple Nephrectomy in a Tertiary Care Safety Net Hospital-Patient Characteristics, Causes, Cost, and Renal Function Implications. 
  • Surgical site infection in the elderly population. 
  • Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. 
  • Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: Lifeline. 
  • Temporal Trends in Incidence and Outcomes of Acute Pancreatitis in Hospitalized Patients in the United States From 2002 to 2013. 
  • Temporal changes in hospital costs for left ventricular assist device implantation. 
  • The Cost of Intramedullary Nailing Versus Skeletal Traction for Treatment of Femoral Shaft Fractures in Malawi: A Prospective Economic Analysis. 
  • The Effects of Turner Syndrome, 45,X on Obstetric and Neonatal Outcomes: A Retrospective Cohort Evaluation. 
  • The Impact of Postoperative Intensive Care Unit Admission on Postoperative Hospital Length of Stay and Costs: A Prespecified Propensity-Matched Cohort Study. 
  • The Ross procedure: shorter hospital stay, decreased morbidity, and cost effective. 
  • The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. 
  • The cost of inefficiency in US hospitals, 1985-1997. 
  • The economics of febrile neutropenia: implications for the use of colony-stimulating factors. 
  • The global cost of pelvic exenteration: in-hospital perioperative costs. 
  • The high cost of critical care unit over-utilization for patients with NSTE ACS. 
  • The impact of diabetes mellitus and renal insufficiency on the outcome of endovascular abdominal aortic aneurysm repair. 
  • The impact of femoral arterial thrombosis in paediatric cardiac catheterisation: a national study. 
  • The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients. 
  • The impact of morbid obesity on resource utilization after renal transplantation. 
  • The impact of prenatally diagnosed Klinefelter Syndrome on obstetric and neonatal outcomes. 
  • The impact of statistical adjustment on economic profiles of interventional cardiologists. 
  • The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. 
  • The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. 
  • The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy. 
  • The medical costs of gunshot injuries in the United States. 
  • The relationship of hospital market concentration, costs, and quality for major surgical procedures. 
  • The use of patient mix-adjusted control charts to compare in-hospital costs of care. 
  • The value proposition in percutaneous coronary intervention. 
  • Total hospital costs of surgical treatment for adult spinal deformity: an extended follow-up study. 
  • Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care. 
  • Understanding the costs of better tuberculosis diagnostics. 
  • VA community-based outpatient clinics: cost performance measures. 
  • Value-Based Care Has Not Resulted in Biased Patient Selection: Analysis of a Single Center's Experience in the Care for Joint Replacement Bundle. 
  • Valuing the work performed by anesthesiology residents and the financial impact on teaching hospitals in the United States of a reduced anesthesia residency program size. 
  • Variability in cost of coronary bypass surgery in New York State: potential for cost savings. 
  • Variation in congenital heart surgery costs across hospitals. 
  • Variations in and correlates of length of stay in academic hospitals among patients with heart failure resulting from systolic dysfunction. 
  • Vasopeptidase inhibitor reduces inhospital costs for patients with congestive heart failure: results from the IMPRESS trial. Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure. 
  • Venous thromboembolism after thoracic/thoracolumbar spinal fusion. 
  • Vertical integration: hospital ownership of physician practices is associated with higher prices and spending. 
  • Walking speed predicts health status and hospital costs for frail elderly male veterans. 
• 

  Keywords of People

  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Myers, Evan Robert, Walter L. Thomas Distinguished Professor of Obstetrics and Gynecology in the School of Medicine, Duke Cancer Institute
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society